The role of cysteines and histidins of the norepinephrine transporter

Neurochemical Research

Volumn 38, Issue 7, 2013, Pages 1303-1314

  Wenge, Birger ^a   Bönisch, Heinz ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antidepressants; Cysteine; Histidin; N Ethylmaleimide; Norepinephrine; Norepinephrine transporter

Indexed keywords

ALANINE; CYSTEINE; HISTIDINE; MUTANT PROTEIN; N ETHYLMALEIMIDE; NISOXETINE; NORADRENALIN TRANSPORTER;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL STRAIN HEK293; CONTROLLED STUDY; DISULFIDE BOND; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR INTERACTION; NORADRENALIN UPTAKE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS;

CYSTEINE; ETHYLMALEIMIDE; FLUOXETINE; HEK293 CELLS; HISTIDINE; HUMANS; MUTAGENESIS, SITE-DIRECTED; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RADIOLIGAND ASSAY; SUBCELLULAR FRACTIONS;

EID: 84878850253     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1022-3     Document Type: Article

References (53)

1. Bönisch H, Brüss M (2006) The norepinephrine transporter in physiology and disease. Handb Exp Pharmacol 175:485-524
2. Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49
3. Chen NH, Reith ME, Quick MW (2004) Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflügers Arch 447:519-531
4. Rudnick G (2006) Serotonin transporters: structure and function. J Membr Biol 213:101-110
5. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354
6. Brüss M, Hammermann R, Brimijoin S, Bönisch H (1995) Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J Biol Chem 270:9197-9201
7. - neurotransmitter transporters. J Neurochem 71:1785-1803
8. Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13-25
9. Wenge B, Bönisch H (2008) N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter. Naunyn Schmiedebergs Arch Pharmacol 377:255-265
10. Wang CI, Shaikh NH, Ramu S, Lewis RJ (2012) A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter. Mol Pharmacol 82:898-909
11. Sørensen L, Andersen J, Thomsen M, Hansen SM, Zhao X, Sandelin A, Stromgaard K, Kristensen AS (2012) Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket. J Biol Chem 287:43694-43707
12. Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ (2007) chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. J Biol Chem 282:17837-17844
13. Andersen J, Stuhr-Hansen N, Zachariassen L, Toubro S, Hansen SM, Eildal JN, Bond AD, Bogeso KP, Bang-Andersen B, Kristensen AS, Stromgaard K (2011) Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters. Proc Natl Acad Sci USA 108:12137-12142
14. Kristensen AS, Andersen J, Jørgensen TN, Sørensen L, Eriksen J, Loland CJ, Stromgaard K, Gether U (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585-640
15. van Iwaarden PR, Driessen AJ, Konings WN (1992) What we can learn from the effects of thiol reagents on transport proteins. Biochim Biophys Acta 1113:161-170
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
17. Reith ME, Wang LC, Dutta AK (2005) Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity. J Neurosci Methods 143:87-94
18. Distelmaier F, Wiedemann P, Brüss M, Bönisch H (2004) Functional importance of the C-terminus of the human norepinephrine transporter. J Neurochem 91:537-546
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
20. Danek Burgess KS, Justice JB Jr (1999) Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport. J Neurochem 73:656-664
21. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD (1998) Acute regulation of norepinephrine transport: i. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther 287:733-743
22. Chen JG, Liu-Chen S, Rudnick G (1997) External cysteine residues in the serotonin transporter. Biochemistry 36:1479-1486
23. Chen R, Wei H, Hill ER, Chen L, Jiang L, Han DD, Gu HH (2007) Direct evidence that two cysteines in the dopamine transporter form a disulfide bond. Mol Cell Biochem 298:41-48
24. Schwartz JW, Novarino G, Piston DW, DeFelice LJ (2005) Substrate binding stoichiometry and kinetics of the norepinephrine transporter. J Biol Chem 280:19177-19184
25. Bednar RA (1990) Reactivity and pH dependence of thiol conjugation to N-ethylmaleimide: detection of a conformational change in chalcone isomerase. Biochemistry 29:3684-3690
26. Sur C, Schloss P, Betz H (1997) The rat serotonin transporter: identification of cysteine residues important for substrate transport. Biochem Biophys Res Commun 241:68-72
27. Nguyen TT, Amara SG (1996) N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J Neurochem 67:645-655
28. Melikian HE, Ramamoorthy S, Tate CG, Blakely RD (1996) Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol Pharmacol 50:266-276
29. Li LB, Chen N, Ramamoorthy S, Chi L, Cui XN, Wang LC, Reith ME (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem 279:21012-21020
30. Mao W, Iwai C, Qin F, Liang CS (2005) Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress. Am J Physiol Heart Circ Physiol 288:2381-2389
31. Ferrer JV, Javitch JA (1998) Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proc Natl Acad Sci USA 95:9238-9243
32. Baty JW, Hampton MB, Winterbourn CC (2002) Detection of oxidant sensitive thiol proteins by fluorescence labeling and two-dimensional electrophoresis. Proteomics 2:1261-1266
33. van Iwaarden PR, Pastore JC, Konings WN, Kaback HR (1991) Construction of a functional lactose permease devoid of cysteine residues. Biochemistry 30:9595-9600
34. Frillingos S, Gonzalez A, Kaback HR (1997) Cysteine-scanning mutagenesis of helix IV and the adjoining loops in the lactose permease of Escherichia coli: Glu126 and Arg144 are essential. off. Biochemistry 36:14284-14290
35. Jung H, Jung K, Kaback HR (1994) Cysteine 148 in the lactose permease of Escherichia coli is a component of a substrate binding site. 1. Site-directed mutagenesis studies. Biochemistry 33:12160-12165
36. Kaback HR, Sahin-Toth M, Weinglass AB (2001) The kamikaze approach to membrane transport. Nat Rev Mol Cell Biol 2:610-620
37. Shahrestanifar M, Wang WW, Howells RD (1996) Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide. J Biol Chem 271:5505-5512
38. Pörzgen P, Bönisch H, Hammermann R, Brüss M (1998) The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons. Biochim Biophys Acta 1398:365-370
39. Kitayama S, Morita K, Dohi T (2001) Functional characterization of the splicing variants of human norepinephrine transporter. Neurosci Lett 312:108-112
40. Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30:121-134
41. + symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol Pharmacol 70:1630-1642
42. Hahn MK, Robertson D, Blakely RD (2003) A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci 23:4470-4478
43. Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, Wang DN (2007) LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317:1390-1393
44. --dependent neurotransmitter transporters. Nature 437:215-223
45. Singh SK, Yamashita A, Gouaux E (2007) Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448:952-956
46. Talvenheimo J, Nelson PJ, Rudnick G (1979) Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. J Biol Chem 254:4631-4635
47. 3H]norepinephrine by primary astrocyte cultures and its inhibition by tricyclic antidepressants. J Neurochem 40:1265-1270
48. Rudnick G (2007) What is an antidepressant binding site doing in a bacterial transporter? ACS Chem Biol 2:606-609
49. Norregaard L, Loland CJ, Gether U (2003) Evidence for distinct sodium-, dopamine-, and cocaine-dependent conformational changes in transmembrane segments 7 and 8 of the dopamine transporter. J Biol Chem 278:30587-30596
50. Mitchell SM, Lee E, Garcia ML, Stephan MM (2004) Structure and function of extracellular loop 4 of the serotonin transporter as revealed by cysteine-scanning mutagenesis. J Biol Chem 279:24089-24099
51. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, Gether U, Loland CJ (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11:780-789
52. Zhen J, Ali S, Dutta AK, Reith ME (2012) Characterization of [ÂH]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive. J Neurosci Methods 203:19-27
53. Stephan MM, Chen MA, Penado KM, Rudnick G (1997) An extracellular loop region of the serotonin transporter may be involved in the translocation mechanism. Biochemistry 36:1322-1328